Antibodies and Related Products
Monoclonal ERCC1 Antibody
March 5, 2013 10:45 am | Product Releases | CommentsTrevigen’s Monoclonal ERCC1 Antibody (4424-AMC-100) recognizes human ERCC1 and is suitable for Western blotting and immunocytochemistry. It is a purified mouse monoclonal antibody raised against full length recombinant human XPF/ERCC1 complex.
LISTED UNDER: DNA
Collagen Antibody Kit Induces Arthritis in 24 Hours
March 1, 2013 2:43 pm | Product Releases | CommentsAMSBIO announced a new 5-Clone Collagen Antibody-Induced Arthritis (CIAA) kit for the induction of Collagen-Induced Arthritis (CIA) in various species.
LISTED UNDER: ProteinsBlocking Key Protein Could Halt Age-related Decline in Immune System
October 1, 2012 7:38 am | News | CommentsScientists have found that blocking the action of a single protein whose levels in our immune cells creep steadily upward with age can restore those cells’ response to a vaccine.
LISTED UNDER: AdjuvantsAdvanced Genetic Screening Method May Speed Vaccine Development
May 10, 2012 7:52 am | News | CommentsA group from ASU used high-throughput methods to identify a modulator of immune activity that exists naturally in an unusual pathogen belonging to the Poxviridae family of viruses.
LISTED UNDER: AdjuvantsModified Vaccine Shows Promise in Preventing Malaria
September 26, 2011 10:55 am | News | CommentsContinuing a global effort to prevent malaria infections, Michigan State University researchers have created a new malaria vaccine - one that combines the use of a disabled cold virus with an immune system-stimulating gene - that appears to increase the immune response against the parasite that causes the deadly disease.
LISTED UNDER: AdjuvantsSearching for combinations that work on resistant bacteria: add antidiarrhea drug?
April 24, 2011 9:36 am | by Anne-Marie Tobin-Associated Press | News | CommentsA decades-old antibiotic appears to work better when combined with a common antidiarrheal drug to combat a persistent bug that often afflicts people with cystic fibrosis, a new study indicates.The synergy between the two drugs was discovered in lab studies by researchers at McMaster University...
LISTED UNDER: AdjuvantsResearch may lead to new and improved vaccines
March 14, 2011 5:42 am | by EurekAlert | News | Comments(University of Calgary) Alum is an adjuvant (immune booster) used in many common vaccines, and Canadian researchers have now discovered how it works. The research by scientists from the University of Calgary's Faculty of Medicine is published in the March 13 online edition of Nature Medicine.
LISTED UNDER: AdjuvantsNIH experts describe influenza vaccines of the future
November 17, 2010 1:45 pm | by EurekAlert | News | Comments(NIH/National Institute of Allergy and Infectious Diseases) In a review article appearing in the New England Journal of Medicine, scientists at NIAID examine research under way to address the limitations of currently available influenza vaccines and develop more efficient and reliable...
LISTED UNDER: AdjuvantsBaxter gets Austrian approval for flu vaccine
September 30, 2010 6:36 am | by The Associated Press | News | CommentsDrug developer Baxter International Inc. said Thursday Austrian regulators approved its seasonal flu vaccine Preflucel.While traditional flu vaccines are cultivated in chicken eggs, Preflucel is made with a technology called Vero cell, and made from a mammalian cell line. The company has said...
LISTED UNDER: AdjuvantsJCI table of contents: Jan. 25, 2010
January 25, 2010 1:43 pm | by EurekAlert | News | Comments( Journal of Clinical Investigation ) This release contains summaries, links to PDFs, and contact information for the following newsworthy papers to be published Jan. 25, 2010, in the JCI: Three is better than two when boosting vaccine effectiveness; Genetic variability in a tumor as...
LISTED UNDER: AdjuvantsMajor breakthrough may pave the way for therapeutic vaccines
December 17, 2009 5:44 am | by EurekAlert | News | Comments( Uppsala University ) It should be possible to use therapeutic vaccines to create both cheap and effective drugs for diseases like cancer and allergies. One problem in developing such vaccines has previously been the lack of adjuvants, substances that make vaccines more effective....
LISTED UNDER: Adjuvants